DARPA calls for antibiotic replacement

November 23, 2011 by Bob Yirka in Medications report
Penicillin

Enlarge

Penicillin, the first natural antibiotic discovered by Alexander Fleming in 1928

(Medical Xpress) -- Most everyone that has been keeping abreast of world events knows that the clock is ticking on antibiotics; bacteria have been slowly developing a resistance and development of new antibiotics has slowed to a crawl, thus the day will soon come that all of the tools were are currently using to fight bacterial infections will be lost, leaving everyone at their mercy. This problem has not gone unnoticed by those at the upper reaches of the military establishment in the United States, thus it should not come as a surprise to anyone that DARPA, via the Small Business Innovation Research (SBIR) program, has issued a Request for Proposals (RFP) to completely replace antibiotics with something new and better.

As noted in the RFP, the military has seen firsthand the problems with current antibiotics; soldiers experiencing in war, especially those involved in fires, that develop bacterial infections now require triple the amount of hospital time to recover as doctor’s plow through a host of in trying to find the one that will work. Clearly frightened at the prospect of sending soldiers into battle where they may encounter bioengineered bacterial agents, the top brass has decided it’s time to take another approach and to get on it now.

Instead of working to develop , DARPA proposes the development and use of so-called nanoparticles to deliver gene altering chemicals directly to the cells of bacteria to kill them. In addition, they are hoping that someone will be able to come up with a way to make it so that the nanoparticles and chemicals they carry can be reprogrammed on-the-fly so as to combat newly evolved or created bacteria as soon as they appear. The idea is that the nanoparticles would carry something called small interfering RNA (siRNA) which are groups of molecules that would actually do the work of shutting down the genes inside the cells of the bacteria.

DARPA has laid out the project in three phases: Study what’s out there now, develop the nanoparticle delivery system and siRNA, and devise a means for rapidly reprogramming them.

On its face, the project seems rather simple, after all, this is not science fiction, DARPA points out that just last year a research group used siRNA delivered by nanoparticles to kill the Ebola virus in four primates. Unfortunately, the problem is, it’s not as easy as it looks, all of this science is still in its infancy and if a way can be found to do what is being asked, it likely will take years, if not decades to fully develop. The success against the Ebola virus was one agent against just one virus in a structured environment. To do what DARPA wants would mean using one technique to kill any and all bad and/or viruses. Also, if it can be done, no one really knows if the procedure would be reprogrammable, much less whether it could be done on-the-fly, so it’s not really clear if anyone will be able to achieve what is asking for; though it seems for the sake of all of us, we better hope so. Turning back the clock to a time when we were helpless against the onslaught of bacterial infections would be difficult to swallow, to say the least.

© 2011 PhysOrg.com

4.7 /5 (15 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

NotAsleep
Nov 23, 2011

Rank: not rated yet
If successful, these methods could be tailored to cure all disease... at some point there will be ethical discussions about who gets access to things like that
gwrede
Nov 23, 2011

Rank: 2.5 / 5 (6)
If the DARPA project doesn't fly, then we all have to learn to eat our veggies and exercise so that our natural defenses work properly. And we have to learn to be careful so we don't physically hurt ourselves, or others.

But who am I kidding? We all know that this is what we should already be doing and we don't, so this new reason won't change anything.
rjsc2000
Nov 23, 2011

Rank: 4 / 5 (1)
Can't they make a chainsaw with nano particles or motors or whatever? Then no bacteria could resist them---
Valentiinro
Nov 23, 2011

Rank: 4.2 / 5 (5)
If the DARPA project doesn't fly, then we all have to learn to eat our veggies and exercise so that our natural defenses work properly. And we have to learn to be careful so we don't physically hurt ourselves, or others.

But who am I kidding? We all know that this is what we should already be doing and we don't, so this new reason won't change anything.


The reason DARPA wants this isn't to protect people against things a regular immune system will help you with. It's to protect against new bio-engineered diseases created as weapons. I think the people designing such diseases will make them powerful enough that broccoli isn't going to do the trick.

Also *preach preach preach*.

Can't they make a chainsaw with nano particles or motors or whatever? Then no bacteria could resist them---


Then they have to make a little Bruce Campbell out of nano-particles. Do you know how hard that would be?!
InsaniD
Nov 23, 2011

Rank: 4 / 5 (3)
If so many people were not Mysophobes, this would not be such a big issue. We spend so much time killing off pathogens and microbes that our bodies need to prepare themselves for fighting disease, forgetting how antibodies work.
Our homes do not need to be sterile. Our kids do not need to be protected from germs. By trying to "protect" ourselves, we only put ourselves in more danger...
TheGhostofOtto1923
Nov 23, 2011

Rank: 1 / 5 (1)
DARPA is just playing with us. They have known how to fight germs for 50 years.
http://www.youtub...a_player

-Not covered by obamacare unfortunately.
Osiris1
Nov 28, 2011

Rank: not rated yet
The biggest problem is that corporate cartel farmers will buy them up and feed them to cattle so they can eat even MORE BST to artificially increase milk production ever more from ever fewer cows with ever narrower population wide genetic diversity. Ordinarily the ultimate end of this is a simple disease kills the entire population virtually overnight. Now an engineered germ passed in milk to us whacks a significant proportion of us. All the enemy need to do is put an 'operative' in as a 'slave' wage alien on a corporate farm with a stock of 'stuff'. Who clears or vets a person making nothing from a society that has it all? Who could. With those who have no stake in a society; conversely that society has no stake in them. I see armies of al qeeda creepin out of the ground to work on these places. Even now the services cannot security vet its menial workers in jobs it loves to 'outsource' to civilians 'to save money'(GS14's gettin bribes from contractors).
Lunarblade
Nov 29, 2011

Rank: not rated yet
It's sad to see that drug companies focus more on profit than what's really important. Drugs for chronic diseases are more profitable when compared to infections. That is why there has not been further research in antimicrobial susceptibility. Physicians are partly to blame for this microbial resistance. If they were not so lax on antibiotic distribution we would not be experiencing resistance to antibiotics at this level. I hope the era of antibiotics doesn't end this soon.
AdamRocket
Dec 04, 2011

Rank: not rated yet
Darpa do you read this?
There is another superior technology to antibiotics already...Phage Therapy. Phages can kill strains that are resistant through biofilms; Now that there is a form of gonorrhea that resist all antibiotics this technology should be combined with nano-particles and SiRna and genetic therapy... Phages can be used to ingect sirna to silence the genes that cause antibiotic resistance!, then the antibiotics can be used in smaller doses to finish the job... get to work darpa
brennemanr
Dec 08, 2011

Rank: not rated yet
read "The Mold in Dr. Florey's Coat"...Flemming only discovered the general phenomenon but Florey and Chain elucidated the actual molecule and worked out the purification process that saved countless GIs in WWII. targeted therapy is the name of the game for the future..evolved ligands to recognize target molecules on pathogens....the details are currently being worked out but the future is here
Rank 4.7 /5 (15 votes)
Relevant PhysicsForums posts
  • Potential Breakthrough in Seizure Control
    created10 hours ago
  • Popping/Cracked sternum.
    created15 hours ago
  • Which Mental Illness Encompasses This Problem?
    created15 hours ago
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Missouri opts for untested drug for executions

(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...

Medications created May 24, 2012 | popularity not rated yet | comments 4

Aspirin may prevent recurrence of deep vein blood clots

(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...

Medications created May 23, 2012 | popularity not rated yet | comments 2 | with audio podcast

Patients may receive too much acetaminophen in hospital

(HealthDay) -- Roughly 2.5 percent of admitted hospital patients may receive more than the safe daily cumulative dose of the pain-reliever acetaminophen, best known as Tylenol, on at least one day, according ...

Medications created May 23, 2012 | popularity 1 / 5 (1) | comments 0

New quality standards limiting elemental impurities in medicines announced

As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters Elemental Impurities—Limits and ...

Medications created May 23, 2012 | popularity not rated yet | comments 0

Quality standards for heparin further strengthened

To help further secure a safe supply of the widely–used blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel ...

Medications created May 23, 2012 | popularity not rated yet | comments 0


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...